Liar - Dawn Jay

Powered by mp3skull.com

Wednesday, September 21, 2011

New doubts about 'poster child' of exoplanets

When it comes to alien worlds, even poster children are fickle. Fomalhaut b – one of the first and only exoplanets to be photographed directlyMovie Camera – may not be what it seems.
Astronomers expected to find a planet orbiting the young, nearby star Fomalhaut since 2005, when Hubble Space Telescope images showed that the star's spectacular dust disc lies a bit off-centre.
Sure enough, in 2008, Paul Kalas of the University of California, Berkeley, and colleagues spotted a wandering speck of light in two separate images taken by the Hubble Space Telescope's Advanced Camera for Surveys in 2004 and 2006.
These were combined to form the image shown (right), which contains two positions for the planet. Fomalhaut b became known as one of the only directly imaged exoplanets.

Disc disruption?

The candidate planet lies about 120 times as far from its star as the Earth lies from the sun, and apparently nestles neatly into a gap in the dust disc. Astronomers suggested that the planet's gravity created an opening in the disc at that spot, the same way that some of Saturn's moons open gaps in its rings.
The trouble is, in the three years since the 2008 discovery, no other telescope had detected the planet.
The Hubble instrument used to take the first images broke in 2007, and will not be repaired. So Kalas and colleagues used an older Hubble camera to take another peek in 2010. As they reported on 12 September, at the Extreme Solar Systems II conference in Moran, Wyoming, this revealed the bright speck again.
This time, however, it was in an unexpected place. "That's a problem," says Steinn Sigurdsson of Pennsylvania State University in University Park, who helped organise the conference. To make sense of it, the planet would need an elliptical orbit that takes it across the dust disc, yet its brightness suggests that it is too big to do so without disrupting the disc.

Hidden planet

That's causing Ray Jayawardhana of the University of Toronto, Canada, to doubt whether the initial images really were of an exoplanet. Jayawardhana was not involved in the planet's discovery but he gave a talk at the same meeting about the problems with imaging exoplanets. "I would say the evidence is confusing and contradictory at best," he says.
Kalas is not giving up. Possible explanations include a second, hidden planet that holds the ring steady and perturbs Fomalhaut b's orbit.
Or it may be that the speck in the newest image is not a planet at all, but a transient dust cloud within the disc, a background star, or a tiny protostar that failed to ignite.
"It will all be solved with observations, probably within the next year," says Kalas. His team is scheduled to observe the Fomalhaut system with Hubble again in 2012.

Data squeeze

The controversy highlights the problems in claiming first dibs on exoplanet discoveries.
"There's a little bit of tension about priorities; who did what first. Things are happening so rapidly that discoveries are overlapping, and sometimes people are trying to get in the door before it slams," Sigurdsson says. "We're squeezing the data till it bleeds. Some of it's going to be wrong, no question."
That concerns Jayawardhana. "I feel a little bit uncomfortable that the poster boy for directly imaged planets is the weakest case or least secure case that we have," he says.
It's not the first exoplanet discovery to be potentially fickle. Just two weeks after the first life-friendly exoplanet was discovered – Gliese 581g – its existence was called into question by members of another team, who didn't see the planet in their data. Gliese 581g's existence still awaits confirmation.

First anti-wrinkle pill shows signs of success

BEAUTY may be no more than skin-deep, but many of us think that leaves plenty of room for improvement. So a new dietary treatment that promises to shrink wrinkles from inside the skin is bound to be big news when it is launched next month.
The makers of the three-a-day capsules say they use blends of natural food extracts to activate genes that improve skin tone - and early results suggest they may be on the right track.
If the results stand up to scrutiny, the capsules will be the first anti-wrinkle treatment to show evidence of combating wrinkling from the deeper layers of skin. But they will not be the first to win scientific backing - some skin creams have been shown in peer-reviewed journals to help reduce wrinkles (British Journal of Dermatology, DOI: 10.1111/j.1365-2133.2009.09436.x).
Independent researchers contacted by New Scientist said that the preliminary results are intriguing and commended the team developing the capsules for conducting a double-blind trial - testing them against a placebo with neither researchers nor recipients knowing until afterwards who had received what. They say they will be sceptical, however, until a peer-reviewed journal has published the results in full, and acknowledge that attempts to erase the signs of ageing don't sit well with everyone.
The "gene food" treatment is the work of John Casey's team at the laboratories of Unilever in Sharnbrook, UK. The multinational food, cosmetics and household products company commissioned four separate research groups to test the capsules, and 480 women in the UK, France and Germany who have passed the menopause took part in the trials.
New Scientist has seen results that show that in 14 weeks, "crow's feet" wrinkles by the corner of the eye became on average 10 per cent shallower in recipients of the capsules, shrinking by 30 per cent in the best responders (see photos). The wrinkles of women who received a placebo did not change significantly in depth.
In one of the two French studies, researchers also took 4-millimetre-deep biopsies from 110 women before and after treatment to study the production of collagen - a protein that is a key structural component of skin. Antibodies that stain tissue red where new collagen is produced revealed that after treatment a fifth of recipients had significantly more fresh collagen in the deepest skin layer - the dermis - than those who had received a placebo. More sensitive tests will be needed to ascertain any differences in the remaining biopsies, says Casey. Partial results were presented at the Society for Investigative Dermatology meeting in Atlanta, Georgia, last year; Casey says that the full data will now be sent to journals for peer review.
So how do these capsules work? As women age and oestrogen production drops off towards menopause, enzymes called proteases become more active, reducing the sponginess of skin by clearing away collagen faster than it can be replaced. An oestrogen receptor that aids the generation of collagen also becomes less active. The two effects combine to make skin less pliable and more wrinkly.
Casey's team used skin cultures and gene activity tests to ascertain the effect of certain natural food extracts on "master" genes, which orchestrate the behaviour of lots of other genes - in this case, those involved in collagen synthesis. The blend that activated these genes most strongly included vitamins C and E plus isoflavones from soya, lycopene from tomatoes and omega-3 polyunsaturated acids from fish oil (see "What's in an anti-wrinkle capsule?").
Unilever plans to launch the product next month in 44 spas that it co-owns in the UK, Spain and Canada. It does not need approval to sell the capsules from these countries' regulatory authorities because the extracts they contain are already in use and the company does not claim that the capsules benefit health.
Although long-term tests have not been carried out, Gail Jenkins, another member of the team, recommends taking three capsules per day for at least three months; at this dose, she says, adverse side effects are unlikely. If a person stopped taking the capsules, the normal ageing process would probably restore deeper wrinkles.
When New Scientist sent the preliminary data to independent dermatologists, they gave a guarded welcome. "The data are somewhat sparse, but they do appear to have done a pretty comprehensive study," says Christopher Griffiths, professor of dermatology at the University of Manchester, UK, and co-author of a 2009 study confirming that an anti-ageing cream produced by Boots, a British pharmacy chain, had anti-wrinkle effects (British Journal of Dermatology, DOI: 10.1111/j.1365-2133.2009.09216.x). Griffiths said he would be "unconvinced" until he had seen all the data, but was intrigued by the apparent repair of deep rather than superficial wrinkles. "I know of no other study that has shown this before," he says. A likely explanation, says Casey, is that creams penetrate only the top layer of skin - the epidermis. The contents of the capsules, by contrast, reach the dermis, stimulating the production of collagen in deeper layers.

Richard Weller, a dermatologist at Edinburgh Royal Infirmary, UK, applauded Unilever for testing the product against a placebo and for saying it will publish the results in full. "What matters is the clinical data, and they show there are reduced wrinkles in the treated group," he says. "I'm not aware of any [other] oral treatments that do this."
David Sarwer of the University of Pennsylvania, Philadelphia, says that the results are encouraging but "we need a number of studies in this area, with similar results and published in the peer-reviewed literature, before we have a sufficient body of evidence to suggest that these supplements positively impact facial appearance".
Nichola Rumsay of the Centre for Appearance Research at the University of the West of England in Bristol says that anti-wrinkle capsules are more psychologically benign than facial surgery, but they still reinforce the message that wrinkles are bad. "We should be accepting wrinkles gracefully. Someone should develop a pill to stop people worrying about their appearance," she says. "That would make people a lot happier."

What's in an anti-wrinkle capsule?

The concept behind "gene foods" is to put back into modern diets the ingredients from berries, nuts and fruits that were abundant in the food of our hunter-gatherer ancestors. Evidence is mounting that many of these ingredients have profound effects on master genes that keep tissue and organs healthy, reducing inflammation and damage.
Unilever's blend includes isoflavones from soya. These activate oestrogen receptors that trigger the skin to make collagen Regulatory Toxicology and Pharmacology, DOI: 10.1016/s0273-2300(03)00091-6). Another ingredient in the capsules is omega-3 polyunsaturated fatty acids taken from fish oil, which activate a master gene called PPAR that is also involved in collagen synthesis (Journal of Lipid Research, DOI: 10.1194/jlr.m800614-jlr200).
The other ingredients are vitamin E, vitamin C and lycopene, all known to promote tissue health. "We put them all together in a single product, and there are about a dozen genetic mechanisms at work," says Casey.
Preliminary results from Unilever suggest that activating the master genes raises the activity of several other genes that make proteins vital for good skin tone, such as elastin, decorin and several anti-inflammatory molecules.

Saturday, September 10, 2011

Batsmen with a century of centuries

Rank↓ 100's↓ Player↓ Nation (100's)↓ County (100's)↓

Career↓ Inns↓ Runs↓ Ave↓
1 199 Jack Hobbs  England (15) Surrey (144)

1905–1934 1,315 61,237 50.65
2 170 Patsy Hendren  England (7+1) Middlesex (119)

1907–1938 1,300 57,611 50.80
3 167 Wally Hammond  England (22+4) Gloucestershire (113)

1923–1950 1,005 50,551 56.10
4 153 Phil Mead  England (4) Hampshire (138)

1905–1936 1,340 55,061 47.67
5 151 Geoffrey Boycott ♠  England (22+3) Yorkshire (103)

1962–1986 1,014 48,426 56.83
6 149 Herbert Sutcliffe  England (16+2) Yorkshire (112)

1919–1945 1,088 50,138 51.95
7 145 Frank Woolley  England (5+3) Kent (122)

1906–1938 1,532 58,969 40.75
8 136 Graeme Hick  England (6) Worcestershire (106)

1985–2008 871 41,112 52.23
9 129 Len Hutton  England (19+1) Yorkshire (85)

1934–1960 814 40,140 55.51
10 128 Graham Gooch  England (20) Essex (94)

1973–2000 990 44,846 49.01
11 126 W. G. Grace  England (2+2) Gloucestershire (49)

1865–1908 1,493 54,896 39.55
12 123 Denis Compton  England (17) Middlesex (67)

1936–1964 839 38,942 51.85
13 122 Tom Graveney  England (11) Gloucestershire (50)
Worcestershire (27)


1948–1972 1,223 47,793 44.91
14 117 Donald Bradman  Australia (29+36) —

1927–1949 338 28,067 95.14
15 114 Viv Richards  West Indies (24+23) Somerset (47)
Glamorgan (10)


1971–1993 796 36,212 49.40
16 113 Mark Ramprakash †  England (2+3) Middlesex (46)
Surrey (60)


1987–present 701 33,244 54.32
17 108 Zaheer Abbas ♠  Pakistan (12+17) Gloucestershire (49)

1965–1987 768 34,843 51.54
18= 107 Andy Sandham  England (2) Surrey (83)

1911–1938 1,000 41,284 44.82
18= 107 Colin Cowdrey  England (22+1) Kent (58)

1950–1976 1,130 42,719 42.89
20 104 Tom Hayward  England (3) Surrey (88)

1893–1914 1,138 43,551 41.79
21= 103 Glenn Turner  New Zealand (7+9) Worcestershire (72)

1964–1983 792 34,346 49.70
21= 103 John Edrich  England (12) Surrey (81)

1956–1978 979 39,790 45.47
23= 102 Les Ames  England (8+4) Kent (78)

1926–1951 951 37,248 43.51
23= 102 Ernest Tyldesley  England (3+1) Lancashire (90)

1909–1936 961 38,874 45.46
23= 102 Dennis Amiss  England (11+1) Warwickshire (78)

1960–1987 1,139 43,423 42.86